blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1827438

EP1827438 - PIPERAZIN DERIVATIVES FOR INHIBITING HUMAN STEAROYL-COA-DESATURASE [Right-click to bookmark this link]
Former [2007/36]PYRIDINE DERIVATIVES FOR INHIBITING HUMAN STEAROYL-COA-DESATURASE
[2014/34]
StatusPatent maintained as amended
Status updated on  07.11.2014
Database last updated on 03.10.2024
Most recent event   Tooltip12.06.2015Change - lapse in a contracting state
New state(s): LV		published on 15.07.2015  [2015/29]
Applicant(s)For all designated states
Xenon Pharmaceuticals Inc.
3650 Gilmore Way
Burnaby, BC V5G 4W8 / CA
[2011/02]
Former [2007/36]For all designated states
XENON PHARMACEUTICALS INC.
3650 Gilmore Way
Burnaby, British Columbia V5G 4W8 / CA
Inventor(s)01 / KAMBOJ, Rajender
5809 Sperling Avenue
Burnaby, British Columbia V5E 2T6 / CA
02 / KODUMURU, Vishnumurthy
211-6577 Royal Oak Avenue
Burnaby, British Columbia V5H 3P3 / CA
 [2007/36]
Representative(s)Grünecker Patent- und Rechtsanwälte PartG mbB
Leopoldstraße 4
80802 München / DE
[N/P]
Former [2014/50]Grünecker, Kinkeldey, Stockmair & Schwanhäusser
Leopoldstrasse 4
80802 München / DE
Former [2008/23]Grünecker, Kinkeldey, Stockmair & Schwanhäusser Anwaltssozietät
Leopoldstrasse 4
80802 München / DE
Former [2007/36]Grünecker, Kinkeldey, Stockmair & Schwanhäusser Anwaltssozietät
Maximilianstrasse 58
80538 München / DE
Application number, filing date05810510.720.09.2005
[2007/36]
WO2005US34136
Priority number, dateUS20040611647P20.09.2004         Original published format: US 611647 P
[2007/36]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2006034446
Date:30.03.2006
Language:EN
[2006/13]
Type: A2 Application without search report 
No.:EP1827438
Date:05.09.2007
Language:EN
The application published by WIPO in one of the EPO official languages on 30.03.2006 takes the place of the publication of the European patent application.
[2007/36]
Type: B1 Patent specification 
No.:EP1827438
Date:12.01.2011
Language:EN
[2011/02]
Type: B2 New European patent specification 
No.:EP1827438
Date:10.12.2014
Language:EN
[2014/50]
Search report(s)International search report - published on:EP26.05.2006
ClassificationIPC:A61K31/496
[2007/36]
CPC:
C07D213/81 (EP,US); A61K31/496 (EP,US); A61P1/16 (EP);
A61P3/00 (EP); A61P3/04 (EP); A61P3/06 (EP);
A61P3/10 (EP); A61P43/00 (EP); A61P9/10 (EP);
A61P9/12 (EP); C07D295/192 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2007/36]
TitleGerman:PIPERAZINE DERIVATE ZUR HEMMUNG DER MENSCHLICHEN STEAROYL-COA-DESATURASE[2014/34]
English:PIPERAZIN DERIVATIVES FOR INHIBITING HUMAN STEAROYL-COA-DESATURASE[2014/34]
French:DERIVES DE LA PIPERAZINE ET LEUR UTILISATION COMME AGENTS THERAPEUTIQUES[2014/34]
Former [2007/36]PYRIDIN-DERIVATE ZUR HEMMUNG DER MENSCHLICHEN STEAROYL-COA-DESATURASE
Former [2007/36]PYRIDINE DERIVATIVES FOR INHIBITING HUMAN STEAROYL-COA-DESATURASE
Former [2007/36]DERIVES HETEROCYCLIQUES ET LEUR UTILISATION COMME AGENTS THERAPEUTIQUES
Entry into regional phase18.04.2007National basic fee paid 
18.04.2007Designation fee(s) paid 
18.04.2007Examination fee paid 
Examination procedure18.04.2007Amendment by applicant (claims and/or description)
18.04.2007Examination requested  [2007/36]
17.04.2008Despatch of a communication from the examining division (Time limit: M04)
06.08.2008Reply to a communication from the examining division
15.06.2009Despatch of a communication from the examining division (Time limit: M02)
25.08.2009Reply to a communication from the examining division
22.10.2009Communication of intention to grant the patent
01.03.2010Fee for grant paid
01.03.2010Fee for publishing/printing paid
15.07.2010Observations by third parties
Divisional application(s)EP10012999.8  / EP2316457
Opposition(s)Opponent(s)01  13.07.2011  19.07.2011  ADMISSIBLE
STRAWMAN LIMITED
34 Lovedon Lane Winchester
Hampshire, SO23 7NU / GB
Opponent's representative
Wroe, Stephanie, et al, et al
D Young & Co LLP
120 Holborn
London
EC1N 2DY / GB
 02  06.10.2011  18.10.2011  ADMISSIBLE
JANSSEN PHARMACEUTICA N.V.
Turnhoutseweg 30
2340 Beerse / BE
Opponent's representative
Uexküll & Stolberg, et al, et al
Partnerschaft von
Patent- und Rechtsanwälten mbB
Beselerstraße 4
22607 Hamburg / DE
 03  12.10.2011  18.10.2011  ADMISSIBLE
Syngenta Crop Protection AG
Schwarzwaldallee 215
4058 Basel / CH
Opponent's representative
Thwaite, Jonathan Simon, et al, et al
Syngenta Crop Protection
Münchwilen AG
Intellectual Property
Schaffhauserstrasse
4332 Stein / CH
 [N/P]
Former [2011/47]
Opponent(s)01  13.07.2011  19.07.2011  ADMISSIBLE
STRAWMAN LIMITED
34 Lovedon Lane Winchester
Hampshire, SO23 7NU / GB
Opponent's representative
Wroe, Stephanie, et al, et al
D Young & Co LLP 120 Holborn London
EC1N 2DY / GB
 02  06.10.2011  18.10.2011  ADMISSIBLE
JANSSEN PHARMACEUTICA N.V.
Turnhoutseweg 30
2340 Beerse / BE
Opponent's representative
UEXKÜLL & STOLBERG, et al, et al
Patentanwälte Beselerstrasse 4
22607 Hamburg / DE
 03  12.10.2011  18.10.2011  ADMISSIBLE
Syngenta Crop Protection AG
Schwarzwaldallee 215
4058 Basel / CH
Opponent's representative
Thwaite, Jonathan Simon, et al, et al
Syngenta Crop Protection Münchwilen AG, Intellectual Property Schaffhauser Strasse
4332 Stein / CH
Former [2011/45]
Opponent(s)01  13.07.2011  19.07.2011  ADMISSIBLE
STRAWMAN LIMITED
34 Lovedon Lane Winchester
Hampshire, SO23 7NU / GB
Opponent's representative
Wroe, Stephanie, et al, et al
D Young & Co LLP 120 Holborn London
EC1N 2DY / GB
 02  06.10.2011    ADMISSIBLE
JANSSEN PHARMACEUTICA N.V.
Turnhoutseweg 30
2340 Beerse / BE
Opponent's representative
UEXKÜLL & STOLBERG
Patentanwälte Beselerstrasse 4
22607 Hamburg / DE
Former [2011/33]
Opponent(s)01  13.07.2011    ADMISSIBLE
STRAWMAN LIMITED
34 Lovedon Lane Winchester
Hampshire, SO23 7NU / GB
Opponent's representative
Wroe, Stephanie, et al, et al
D Young & Co LLP 120 Holborn London
EC1N 2DY / GB
17.11.2011Invitation to proprietor to file observations on the notice of opposition
05.09.2012Reply of patent proprietor to notice(s) of opposition
23.01.2014Date of oral proceedings
27.02.2014Despatch of interlocutory decision in opposition
27.02.2014Despatch of minutes of oral proceedings
04.07.2014Legal effect of interlocutory decision in opposition
28.07.2014Despatch of communication that the patent will be maintained as amended
29.09.2014Fee for printing new specification paid
Appeal following opposition09.05.2014Appeal received No.  T1068/14
04.07.2014Result of appeal procedure: appeal of the opponent withdrawn
Fees paidRenewal fee
26.09.2007Renewal fee patent year 03
25.09.2008Renewal fee patent year 04
25.09.2009Renewal fee patent year 05
27.09.2010Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT12.01.2011
BE12.01.2011
CY12.01.2011
CZ12.01.2011
DK12.01.2011
EE12.01.2011
FI12.01.2011
HU12.01.2011
LT12.01.2011
LV12.01.2011
NL12.01.2011
PL12.01.2011
RO12.01.2011
SE12.01.2011
SI12.01.2011
SK12.01.2011
TR12.01.2011
BG12.04.2011
GR13.04.2011
IS12.05.2011
PT12.05.2011
IE20.09.2011
LU20.09.2011
CH30.09.2011
LI30.09.2011
MC30.09.2011
[2015/29]
Former [2015/24]AT12.01.2011
BE12.01.2011
CY12.01.2011
CZ12.01.2011
DK12.01.2011
EE12.01.2011
FI12.01.2011
HU12.01.2011
LT12.01.2011
NL12.01.2011
PL12.01.2011
RO12.01.2011
SE12.01.2011
SI12.01.2011
SK12.01.2011
TR12.01.2011
BG12.04.2011
GR13.04.2011
IS12.05.2011
PT12.05.2011
IE20.09.2011
LU20.09.2011
CH30.09.2011
LI30.09.2011
MC30.09.2011
Former [2013/45]AT12.01.2011
BE12.01.2011
CY12.01.2011
CZ12.01.2011
DK12.01.2011
EE12.01.2011
FI12.01.2011
HU12.01.2011
LT12.01.2011
LV12.01.2011
NL12.01.2011
PL12.01.2011
RO12.01.2011
SE12.01.2011
SI12.01.2011
SK12.01.2011
TR12.01.2011
BG12.04.2011
GR13.04.2011
IS12.05.2011
PT12.05.2011
IE20.09.2011
LU20.09.2011
CH30.09.2011
LI30.09.2011
MC30.09.2011
Former [2013/44]AT12.01.2011
BE12.01.2011
CY12.01.2011
CZ12.01.2011
DK12.01.2011
EE12.01.2011
FI12.01.2011
LT12.01.2011
LV12.01.2011
NL12.01.2011
PL12.01.2011
RO12.01.2011
SE12.01.2011
SI12.01.2011
SK12.01.2011
TR12.01.2011
BG12.04.2011
GR13.04.2011
IS12.05.2011
PT12.05.2011
IE20.09.2011
LU20.09.2011
CH30.09.2011
LI30.09.2011
MC30.09.2011
Former [2011/37]BE12.01.2011
CY12.01.2011
FI12.01.2011
LT12.01.2011
LV12.01.2011
PL12.01.2011
SE12.01.2011
SI12.01.2011
BG12.04.2011
GR13.04.2011
IS12.05.2011
PT12.05.2011
Former [2011/36]LT12.01.2011
LV12.01.2011
PL12.01.2011
SE12.01.2011
GR13.04.2011
IS12.05.2011
PT12.05.2011
Cited inInternational search[PX]WO2005011654  (XENON PHARMACEUTICALS INC [CA], et al) [PX] 1-18 * the whole document * * examples 1-4 * * claims 1-71 *;
 [PX]WO2005011655  (XENON PHARMACEUTICALS INC [CA], et al) [PX] 1-18 * the whole document * * examples 1-32 * * claims 1-91 *;
 [PX]WO2005011656  (XENON PHARMACEUTICALS INC [CA], et al) [PX] 1-18 * the whole document * * examples 1-5 * * claims 1-51 *;
 [PX]WO2005011657  (XENON PHARMACEUTICALS INC [CA], et al) [PX] 1-18 * the whole document * * examples 1-4 * * claims 1-51 *;
 [A]  - COHEN, P; NTAMBI, J M; FRIEDMAN, J M, "Stearoyl-CoA desaturase-1 and the metabolic syndrome", CURENT DRUG TARGETS: IMMUNE, ENDOCRINE AND METABOLIC DISORDERS, (2003), vol. 3, no. 4, pages 271 - 280, XP009063538 [A] 1-17 * the whole document *

DOI:   http://dx.doi.org/10.2174/1568013023358843
OppositionWO03043636
 WO03105853
 WO2004011430
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.